Biotinylated Human BTLA (31-150) (M105V, G138S, V148M) Protein, His, Avitag™ (MALS verified) | BTA-H82E5-200ug

Biotinylated Human BTLA (31-150) (M105V, G138S, V148M) Protein, His, Avitag™ (MALS verified) | BTA-H82E5-200ug| Gentaur Distribution US, UK & Europe

B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.

Source: Biotinylated Human BTLA (31-150) (M105V, G138S, V148M), His, Avitag (BTA-H82E5) is expressed from human 293 cells (HEK293). It contains AA Lys 31 - Ser 150 (Accession # AAP44003.1 (M105V, G138S, V148M) ).

Format: Powder.

Tag: C-10×His & C-Avi.

Expression System: HEK293.

Expression Region: Lys 31 - Ser 150.

Conjugate: Biotin-labeled.

Molecular Weight: 17.3 kDa.

Characteristics: This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™). The protein has a calculated MW of 17.3 kDa. The protein migrates as 30-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Purity: 90%.

Buffer: PBS, pH7.4.

Storage Conditions: -20℃.

Shipping Conditions: RT